Literature DB >> 27980496

Reversal of Irritable Bowel Syndrome, Sleep Disturbance, and Fatigue With an Elimination Diet, Lifestyle Modification, and Dietary Supplements: A Case Report.

Stephanie Davis1.   

Abstract

BACKGROUND: A 53-y-old Caucasian patient presented in August 2015 with chief complaints of irritable bowel syndrome (IBS; gas/bloating, gastroesophageal reflux), fatigue, and sleep disturbances. He also noted a history of chronic sinusitis, seasonal allergies, multiple chemical sensitivities, and right knee pain (3 surgeries). His primary care physician, in 2014, diagnosed prediabetes based on an elevated hemoglobin A1c and high-sensitivity C-reactive protein, which was treated with diet and lifestyle modification. CASE/INTERVENTION: In the course of 6 mo, the patient was treated using an elimination diet, lifestyle modifications, botanicals, and dietary supplements. By addressing the underlying cause of issues, his symptoms decreased and quality of life increased, resulting in the resolution of his IBS symptoms, improved sleep, and increased energy levels.
CONCLUSION: This case illustrates the potential diagnostic importance of early testing for gut microbiome imbalances and gastrointestinal infections in the management of IBS as well as the usefulness of a systems-based approach for diagnostic assessment and management of a complex chronic case.

Entities:  

Year:  2016        PMID: 27980496      PMCID: PMC5145014     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  11 in total

Review 1.  A role for the gut microbiota in IBS.

Authors:  Stephen M Collins
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-04-22       Impact factor: 46.802

Review 2.  Nutritional aspects of Helicobacter pylori infection.

Authors:  G Vitale; F Barbaro; G Ianiro; V Cesario; G Gasbarrini; F Franceschi; A Gasbarrini
Journal:  Minerva Gastroenterol Dietol       Date:  2011-12

Review 3.  Review article: an integrated approach to the irritable bowel syndrome.

Authors:  D A Drossman
Journal:  Aliment Pharmacol Ther       Date:  1999-05       Impact factor: 8.171

Review 4.  Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Authors:  Traci L Testerman; James Morris
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 5.  Role of Helicobacter pylori infection on nutrition and metabolism.

Authors:  Francesco Franceschi; Tortora Annalisa; Di Rienzo Teresa; D'Angelo Giovanna; Gianluca Ianiro; Scaldaferri Franco; Gerardi Viviana; Tesori Valentina; Lopetuso Loris Riccardo; Gasbarrini Antonio
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

6.  Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.

Authors:  A P S Hungin; L Chang; G R Locke; E H Dennis; V Barghout
Journal:  Aliment Pharmacol Ther       Date:  2005-06-01       Impact factor: 8.171

Review 7.  Part 1: The Human Gut Microbiome in Health and Disease.

Authors:  Matthew J Bull; Nigel T Plummer
Journal:  Integr Med (Encinitas)       Date:  2014-12

8.  The CARE guidelines: consensus-based clinical case report guideline development.

Authors:  Joel J Gagnier; Gunver Kienle; Douglas G Altman; David Moher; Harold Sox; David Riley
Journal:  J Clin Epidemiol       Date:  2013-09-12       Impact factor: 6.437

9.  The gut microbiota and irritable bowel syndrome: friend or foe?

Authors:  Uday C Ghoshal; Ratnakar Shukla; Ujjala Ghoshal; Kok-Ann Gwee; Siew C Ng; Eamonn M M Quigley
Journal:  Int J Inflam       Date:  2012-04-22

Review 10.  The epidemiology of irritable bowel syndrome.

Authors:  Caroline Canavan; Joe West; Timothy Card
Journal:  Clin Epidemiol       Date:  2014-02-04       Impact factor: 4.790

View more
  1 in total

Review 1.  Biomolecules from Plant Wastes Potentially Relevant in the Management of Irritable Bowel Syndrome and Co-Occurring Symptomatology.

Authors:  Ioana-Miruna Balmus; Dana Copolovici; Lucian Copolovici; Alin Ciobica; Dragos Lucian Gorgan
Journal:  Molecules       Date:  2022-04-08       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.